FAAH Availability in Psychiatric Disorders: A PET Study

Summary

The aim of the present study is to examine Fatty Acid Amide Hydrolase (FAAH) availability in humans, including healthy individuals and across a spectrum of psychiatric disorders in which alterations in the endocannabinoid system are observed.

Timeline

Start

2020-09-23

Primary completion

2021-06-30

Completion

2021-06-30

Outcome

Outcome not reported

Stopped: “Ligand was not effective.”

Drugs

Indications